• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Will digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?

January 29, 2020 by SharpBrains

___

Akili Inter­ac­tive: Dig­i­tal pedi­atric ADHD ther­a­peu­tic per­forms well with or with­out accom­pa­ny­ing stim­u­lant ther­a­py (Mobi­Health News):

“Dig­i­tal ther­a­peu­tic com­pa­ny Akili Inter­ac­tive has announced the first results of an open-label, mul­ti­site pedi­atric ADHD tri­al pro­vid­ing some patients with the company’s video game-like treat­ment along­side a stim­u­lant medication.

Accord­ing to the com­pa­ny, both those who received the AKL-T01 ther­a­py with (n = 130) or with­out (n = 76) accom­pa­ny­ing stim­u­lant med­ica­tion saw sig­nif­i­cant improve­ments one month after base­line (p < .001) as mea­sured by the trial’s pri­ma­ry out­come, rat­ings on the ADHD Impair­ment Rat­ing Scale (IRS) report­ed by par­ents … While a full report­ing of the study data is still being pre­pared for upcom­ing con­fer­ences or jour­nal pub­li­ca­tion, Akili views these find­ings as evi­dence that AKL-T01 pro­vides a ben­e­fit “inde­pen­dent of whether the chil­dren were on or off ADHD medication.”

The Study:

Akili Study of AKL-T01 With and With­out Stim­u­lant Med­ica­tion in Chil­dren With ADHD Achieves Pri­ma­ry Effi­ca­cy End­point (press release):

“Fol­low­ing our suc­cess­ful piv­otal STARS-ADHD study of AKL-T01 as a poten­tial treat­ment for inat­ten­tion in chil­dren with ADHD not tak­ing stim­u­lant med­ica­tions, under­stand­ing the ben­e­fit of our tech­nol­o­gy when used along­side ADHD med­ica­tions has been a research pri­or­i­ty for us. Impor­tant­ly, par­ents see improve­ments in their chil­dren regard­less of whether they are using the treat­ment alone or along­side stim­u­lants,” said Eddie Mar­tuc­ci, CEO of Akili. “As we con­tin­ue to work toward FDA clear­ance for this nov­el ther­a­peu­tic for inat­ten­tion in chil­dren with ADHD, these data and the ben­e­fits expressed by par­ents and physi­cians in this study lend fur­ther cre­dence to the impor­tant role AKL-T01 can play in the treat­ment of ADHD.”

More than 5.5 mil­lion chil­dren diag­nosed with ADHD strug­gle with atten­tion issues. Inat­ten­tion and oth­er “silent” cog­ni­tive issues often go unrec­og­nized in the face of oth­er more overt dis­ease symp­toms, yet they sig­nif­i­cant­ly impact dai­ly func­tion­ing. “Chil­dren with ADHD are joined by mil­lions of oth­ers, both with and with­out med­ical diag­noses, who expe­ri­ence chal­lenges in their dai­ly lives due to inat­ten­tion or oth­er cog­ni­tive issues. We’re com­mit­ted to dri­ving greater aware­ness and recog­ni­tion of the impact of these cog­ni­tive issues and advanc­ing nov­el approach­es to help all those affect­ed,” said Anil Jina, M.D., Akili’s Chief Med­ical Officer.

News in Context:

  • Study: Hav­ing ADHD costs $1.1 mil­lion in low­er life­time earn­ings, even when “treat­ed”
  • Rein­vent­ing Brain Med­i­cine, Phar­ma adopts Dig­i­tal Ther­a­peu­tics: Evi­dence-based videogames, smart­phone apps, and sensors
  • Pend­ing FDA review and approval, research find­ings pave way for Akili’s EVO to become first brain train­ing plat­form pre­scribed for ADHD
  • The FDA cre­ates new Dig­i­tal Health unit to reimag­ine reg­u­la­to­ry paths in the age of scal­able, AI-enhanced innovation

 

How to address pri­va­cy, eth­i­cal and reg­u­la­to­ry issues: Exam­ples in cog­ni­tive enhance­ment, depres­sion and ADHD from Sharp­Brains

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Attention & ADD/ADHD, Brain/ Mental Health, Technology & Innovation Tagged With: adhd, ADHD trial, ADHD-medication, Akili Interactive, AKL-T01, cognitive, cognitive issues, digital therapeutic, FDA clearance, non-invasive neurotechnologies, non-invasive neurotechnology, stimulant medication, video game-like treatment

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 35,214 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy